Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia

Published:2018-07-12 Issue:7 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sadaf Alina¹,Hasan Babar²,Das Jai K³,Colan Steven⁴,Alvi Najveen⁵

Affiliation:

1. University of Florida, Sacred Heart Children's Hospital; 6th Floor Nemours 5153 North 9th Avenue Pensacola Florida USA 32504

2. Aga Khan University Hospital; Department of Paediatrics and Child Health; Stadium Road PO Box 3500 Karachi Sindh Pakistan 74800

3. Aga Khan University Hospital; Division of Women and Child Health; Stadium Road PO Box 3500 Karachi Sind Pakistan

4. Boston Children's Hospital; Department of Cardiology; 300 Longwood Avenue Bader, 2nd Floor Boston Massachusetts USA MA 02115

5. Aga Khan University; Department of Pediatrics; Stadium Road Karachi Pakistan 74800

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011626.pub2/epdf/full

Reference89 articles.

1. Amlodipine reduces cardiac iron overload in patients with thalassemia major: a pilot trial;Fernandes;American Journal of Medicine,2013

2. A randomised trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major;Fernandes;Blood,2016

3. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia;Cappellini;Blood,2006

4. Deferasirox pharmacokinetics in patients with adequate versus inadequate response;Chirnomas;Blood,2009

5. Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone;Lai;Blood Cells, Molecules and Diseases,2010

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deferasirox exerts anti-epileptic effects by improving brain iron homeostasis via regulation of ITPRIP;Neurochemistry International;2024-06

2. Amlodipine Therapy in β-Thalassemia Patients: A Systematic Review and Meta-Analysis on Ferritin Levels and Liver MRI T2*;Thalassemia Reports;2023-12-11

3. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemia;Cochrane Database of Systematic Reviews;2023-11-17

4. Iron chelators as a therapeutic option for Alzheimer’s disease—A mini-review;Frontiers in Aging;2023-08-02

5. An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment;Hemoglobin;2023-03-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3